Back to search

Article

Cancer Immunotherapy Implementation in Crisis-Affected MENA Settings (Lebanon, Sudan, and Iraq): A Pilot Descriptive-Analytical Cross-Sectional Study of Barriers, Clinical Readiness, and Policy Priorities

2026-07-21

Abstract excerpt

<title>Abstract</title> <p>Background Cancer immunotherapy has transformed oncological practice globally, yet its penetration in conflict-affected and resource-constrained Middle Eastern and North African (MENA) countries remains poorly documented. Lebanon, Sudan, and Iraq represent a uniquely vulnerable triad, each experiencing compounding crises of armed conflict, economic collapse, and systemic healthcare dete...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bd346c36-3078-5321-b3a8-885ba46c5ed3
DOI
10.21203/rs.3.rs-10419096/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cancer Immunotherapy Implementation in Crisis-Affected MENA Settings (Lebanon, Sudan, and Iraq): A Pilot Descriptive-Analytical Cross-Sectional Study of Barriers, Clinical Readiness, and Policy PrioritiesDOI 10.21203/rs.3.rs-10419096/v1
Assessing the adoption and impact of decentralized clinical trial approaches in Africa: a multi-country surveySemantic proximity
Global Inequities in Precision Oncology Drug Development: A Cross-Sectional Analysis of FDA Approvals Between 2017-2024Semantic proximity
Success Rates and Timelines of African-Inclusive Phase III Trials: A Retrospective AnalysisSemantic proximity
Success Rates and Timelines of African-Inclusive Phase III Trials: A Retrospective AnalysisSemantic proximity
Participation and Refusal in an Implementation Trial: Insights from the Accelerating Cervical Cancer Elimination through the Integration of Screen-and-Treat Services (ACCESS) StudySemantic proximity
Access barriers to anti-CD19+ CART therapy for NHL across a community transplant and cellular therapy networkSemantic proximity
How cancer patients perceive clinical trials (CTs) in the era of CTs: <i>Current perceptional status and differences between common and rare cancers</i>Semantic proximity
“It’s not about the money, money” - Well, actually it is. Divergent views on drivers of early phase clinical trial participation among ethnically diverse potential trial participants in the United Kingdom: A Mixed Methods StudySemantic proximity
Investigation of Anxiety Sensitivity Levels of Cancer Patients In Terms of Covid 19 Vaccine: A Cross-Sectional StudySemantic proximity
Current practices, challenges, and future directions in subcutaneous oncology monoclonal antibody delivery: A qualitative studySemantic proximity
Barriers to overcome for effective cancer control in Africa.Semantic proximity
Post-trial access practices in conducted clinical trials for Malaria, Tuberculosis, and Neglected Tropical Diseases (NTDs) across Sub-Saharan African countries: A quantitative studySemantic proximity
Select a neighboring publication to make it the new centre.